Copyright Reports & Markets. All rights reserved.

Global Human Vaccination Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Human Vaccination by Type
    • 1.3.1 Overview: Global Human Vaccination Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Human Vaccination Consumption Value Market Share by Type in 2024
    • 1.3.3 Inactivated Vaccine
    • 1.3.4 Live-attenuated Vaccine
    • 1.3.5 mRNA Vaccine
    • 1.3.6 Conjugate Vaccine
    • 1.3.7 Other
  • 1.4 Global Human Vaccination Market by Application
    • 1.4.1 Overview: Global Human Vaccination Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Government Institution
    • 1.4.3 Private Sector
    • 1.4.4 Other
  • 1.5 Global Human Vaccination Market Size & Forecast
  • 1.6 Global Human Vaccination Market Size and Forecast by Region
    • 1.6.1 Global Human Vaccination Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Human Vaccination Market Size by Region, (2020-2031)
    • 1.6.3 North America Human Vaccination Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Human Vaccination Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Human Vaccination Market Size and Prospect (2020-2031)
    • 1.6.6 South America Human Vaccination Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Human Vaccination Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Human Vaccination Product and Solutions
    • 2.1.4 GSK Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 GSK Recent Developments and Future Plans
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Human Vaccination Product and Solutions
    • 2.2.4 Merck Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Merck Recent Developments and Future Plans
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Human Vaccination Product and Solutions
    • 2.3.4 Sanofi Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Sanofi Recent Developments and Future Plans
  • 2.4 Sinovac
    • 2.4.1 Sinovac Details
    • 2.4.2 Sinovac Major Business
    • 2.4.3 Sinovac Human Vaccination Product and Solutions
    • 2.4.4 Sinovac Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sinovac Recent Developments and Future Plans
  • 2.5 Zhejiang Pukang
    • 2.5.1 Zhejiang Pukang Details
    • 2.5.2 Zhejiang Pukang Major Business
    • 2.5.3 Zhejiang Pukang Human Vaccination Product and Solutions
    • 2.5.4 Zhejiang Pukang Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Zhejiang Pukang Recent Developments and Future Plans
  • 2.6 Changchun Institute of Biological
    • 2.6.1 Changchun Institute of Biological Details
    • 2.6.2 Changchun Institute of Biological Major Business
    • 2.6.3 Changchun Institute of Biological Human Vaccination Product and Solutions
    • 2.6.4 Changchun Institute of Biological Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Changchun Institute of Biological Recent Developments and Future Plans
  • 2.7 KM Biologics
    • 2.7.1 KM Biologics Details
    • 2.7.2 KM Biologics Major Business
    • 2.7.3 KM Biologics Human Vaccination Product and Solutions
    • 2.7.4 KM Biologics Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 KM Biologics Recent Developments and Future Plans
  • 2.8 IMBCAMS
    • 2.8.1 IMBCAMS Details
    • 2.8.2 IMBCAMS Major Business
    • 2.8.3 IMBCAMS Human Vaccination Product and Solutions
    • 2.8.4 IMBCAMS Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 IMBCAMS Recent Developments and Future Plans
  • 2.9 Convac
    • 2.9.1 Convac Details
    • 2.9.2 Convac Major Business
    • 2.9.3 Convac Human Vaccination Product and Solutions
    • 2.9.4 Convac Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Convac Recent Developments and Future Plans
  • 2.10 NCPC
    • 2.10.1 NCPC Details
    • 2.10.2 NCPC Major Business
    • 2.10.3 NCPC Human Vaccination Product and Solutions
    • 2.10.4 NCPC Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 NCPC Recent Developments and Future Plans
  • 2.11 Bio Kangtai
    • 2.11.1 Bio Kangtai Details
    • 2.11.2 Bio Kangtai Major Business
    • 2.11.3 Bio Kangtai Human Vaccination Product and Solutions
    • 2.11.4 Bio Kangtai Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Bio Kangtai Recent Developments and Future Plans
  • 2.12 Dynavax
    • 2.12.1 Dynavax Details
    • 2.12.2 Dynavax Major Business
    • 2.12.3 Dynavax Human Vaccination Product and Solutions
    • 2.12.4 Dynavax Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Dynavax Recent Developments and Future Plans
  • 2.13 Hissen
    • 2.13.1 Hissen Details
    • 2.13.2 Hissen Major Business
    • 2.13.3 Hissen Human Vaccination Product and Solutions
    • 2.13.4 Hissen Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Hissen Recent Developments and Future Plans
  • 2.14 KM Biologics
    • 2.14.1 KM Biologics Details
    • 2.14.2 KM Biologics Major Business
    • 2.14.3 KM Biologics Human Vaccination Product and Solutions
    • 2.14.4 KM Biologics Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 KM Biologics Recent Developments and Future Plans
  • 2.15 LG Life Sciences
    • 2.15.1 LG Life Sciences Details
    • 2.15.2 LG Life Sciences Major Business
    • 2.15.3 LG Life Sciences Human Vaccination Product and Solutions
    • 2.15.4 LG Life Sciences Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 LG Life Sciences Recent Developments and Future Plans
  • 2.16 Serum Institute
    • 2.16.1 Serum Institute Details
    • 2.16.2 Serum Institute Major Business
    • 2.16.3 Serum Institute Human Vaccination Product and Solutions
    • 2.16.4 Serum Institute Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Serum Institute Recent Developments and Future Plans
  • 2.17 Pfizer
    • 2.17.1 Pfizer Details
    • 2.17.2 Pfizer Major Business
    • 2.17.3 Pfizer Human Vaccination Product and Solutions
    • 2.17.4 Pfizer Human Vaccination Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Pfizer Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Human Vaccination Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Human Vaccination by Company Revenue
    • 3.2.2 Top 3 Human Vaccination Players Market Share in 2024
    • 3.2.3 Top 6 Human Vaccination Players Market Share in 2024
  • 3.3 Human Vaccination Market: Overall Company Footprint Analysis
    • 3.3.1 Human Vaccination Market: Region Footprint
    • 3.3.2 Human Vaccination Market: Company Product Type Footprint
    • 3.3.3 Human Vaccination Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Human Vaccination Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Human Vaccination Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Human Vaccination Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Human Vaccination Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Human Vaccination Consumption Value by Type (2020-2031)
  • 6.2 North America Human Vaccination Market Size by Application (2020-2031)
  • 6.3 North America Human Vaccination Market Size by Country
    • 6.3.1 North America Human Vaccination Consumption Value by Country (2020-2031)
    • 6.3.2 United States Human Vaccination Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Human Vaccination Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Human Vaccination Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Human Vaccination Consumption Value by Type (2020-2031)
  • 7.2 Europe Human Vaccination Consumption Value by Application (2020-2031)
  • 7.3 Europe Human Vaccination Market Size by Country
    • 7.3.1 Europe Human Vaccination Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Human Vaccination Market Size and Forecast (2020-2031)
    • 7.3.3 France Human Vaccination Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Human Vaccination Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Human Vaccination Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Human Vaccination Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Human Vaccination Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Human Vaccination Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Human Vaccination Market Size by Region
    • 8.3.1 Asia-Pacific Human Vaccination Consumption Value by Region (2020-2031)
    • 8.3.2 China Human Vaccination Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Human Vaccination Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Human Vaccination Market Size and Forecast (2020-2031)
    • 8.3.5 India Human Vaccination Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Human Vaccination Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Human Vaccination Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Human Vaccination Consumption Value by Type (2020-2031)
  • 9.2 South America Human Vaccination Consumption Value by Application (2020-2031)
  • 9.3 South America Human Vaccination Market Size by Country
    • 9.3.1 South America Human Vaccination Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Human Vaccination Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Human Vaccination Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Human Vaccination Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Human Vaccination Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Human Vaccination Market Size by Country
    • 10.3.1 Middle East & Africa Human Vaccination Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Human Vaccination Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Human Vaccination Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Human Vaccination Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Human Vaccination Market Drivers
  • 11.2 Human Vaccination Market Restraints
  • 11.3 Human Vaccination Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Human Vaccination Industry Chain
  • 12.2 Human Vaccination Upstream Analysis
  • 12.3 Human Vaccination Midstream Analysis
  • 12.4 Human Vaccination Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Vaccination market size was valued at US$ 61700 million in 2024 and is forecast to a readjusted size of USD 78630 million by 2031 with a CAGR of 3.6% during review period.
    A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Human Vaccination market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Vaccination market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Human Vaccination market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Human Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Human Vaccination market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Vaccination
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Vaccination market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac, NCPC, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Human Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Inactivated Vaccine
    Live-attenuated Vaccine
    mRNA Vaccine
    Conjugate Vaccine
    Other
    Market segment by Application
    Government Institution
    Private Sector
    Other
    Market segment by players, this report covers
    GSK
    Merck
    Sanofi
    Sinovac
    Zhejiang Pukang
    Changchun Institute of Biological
    KM Biologics
    IMBCAMS
    Convac
    NCPC
    Bio Kangtai
    Dynavax
    Hissen
    KM Biologics
    LG Life Sciences
    Serum Institute
    Pfizer
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Human Vaccination product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Human Vaccination, with revenue, gross margin, and global market share of Human Vaccination from 2020 to 2025.
    Chapter 3, the Human Vaccination competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Human Vaccination market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Human Vaccination.
    Chapter 13, to describe Human Vaccination research findings and conclusion.

    Buy now